# Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/par-21-252-emerging-global-leader-award-k43-independent-clinical-trial/  
Official notice: https://www.grants.gov/search-results-detail/335611

> National Institutes of Health offered grants to the applicants described in the notice. Applications closed on October 14, 2024.

| Field | Value |
|---|---|
| Opportunity number | PAR-21-252 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | October 14, 2024 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.113, 93.121, 93.172, 93.242, 93.398, 93.853, 93.989 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Only non-domestic (non-U.S.) Entities (Foreign Institutions) in Low- or Middle-Income Countries are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

## What the grant funds

This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA PAR-. The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups , including low-income, lower-middle-income, and upper-middle-income countries). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.

## Questions people ask

### Is PAR-21-252 still open?

No. It closed on October 14, 2024. A newer notice is open: PAR-24-296, due dates in the notice, expires December 3, 2026.

### Who can apply for Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)?

Closed October 14, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under PAR-21-252?

NIH RePORTER lists 28 projects funded under PAR-21-252 in fiscal 2022 to 2026, at 20 institutions. The most were at Stellenbosch University, University of Cape Town, Mbarara University/Science/ Technology.

### Who has won Environmental Health grants before?

The largest recipients over five fiscal years were Icahn School of Medicine at Mount Sinai, The Trustees of Columbia University in the City of New York, University of North Carolina at Chapel Hill. The program made 1,980 awards worth $2.1 billion in that time.